Basic Information
| LncRNA/CircRNA Name | XLOC_039890 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | colorectal cancer |
| ICD-0-3 | C19.9 |
| Methods | RNA-seq, qPCR etc. |
| Sample | CRC tissues, cell lines (HCT116, HT29, SW480, SW620, RKO, DLD1, LOVO, DKO, LS180, CaCO2) |
| Expression Pattern | down-regulated |
| Function Description | Lnc-64 (XLOC_039890) was highly expressed in DKO cells, but the expression was lost in HCT116, HT29, SW480, SW620, RKO, DLD1, LOVO, LS180 and CaCO2 cells. The expression was reduced in 81.3% (13/16) of primary colorectal cancer, but it was highly expressed in normal colorectal mucosa. |
| Pubmed ID | 27115166 |
| Year | 2016 |
| Title | Systematic study of novel lncRNAs in different gastrointestinal cancer cells. |
External Links
| Links for XLOC_039890 | GenBank HGNC NONCODE |
| Links for colorectal cancer | OMIM COSMIC |